{"id":"W4400723326","doi":"10.1056/nejmoa2314585","title":"Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease","year":2024,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"AbbVie","keywords":"Ustekinumab; Crohn's disease; Medicine; Crohn disease; Dermatology; Internal medicine; Disease; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003721686,0.0001603848,0.0001944615,0.0001092814,0.00005082681,0.00002962822,0.0001806713,0.00006368756,0.000120516],"category_scores_gemma":[0.0005275111,0.0001164886,0.0001282288,0.0000660646,0.00004464365,0.000009252641,0.00003304767,0.0001298034,0.00000932803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003750749,"about_ca_system_score_gemma":0.0004897176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004769278,"about_ca_topic_score_gemma":0.00001699586,"domain_scores_codex":[0.9989572,0.00004830457,0.0003354773,0.0001961443,0.0002532061,0.000209739],"domain_scores_gemma":[0.9989188,0.00006235704,0.00008047101,0.0001969109,0.0001636567,0.0005777559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1459646,0.0001363317,0.0008740043,0.0006106698,0.001009355,0.008412479,0.001081618,0.005731989,0.01977315,0.001403315,0.626414,0.1885884],"study_design_scores_gemma":[0.103286,0.002900581,0.01639341,0.0008028335,0.0008113182,0.0004556393,0.0001796498,0.001621907,0.001379317,0.002102501,0.8694994,0.0005674923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774399,0.004458045,0.009915872,0.003847734,0.003136235,0.0003208116,0.00004820229,0.00001659089,0.0008165583],"genre_scores_gemma":[0.9891899,0.0001322834,0.0004577277,0.0004637464,0.008381881,0.000007011374,0.00003438952,0.00003330302,0.001299747],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2430854,"threshold_uncertainty_score":0.4750268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01624456847453836,"score_gpt":0.2855549684057032,"score_spread":0.2693103999311648,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}